Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist Cetrorelix with growth inhibition

Stefan Buchholz, Stephan Seitz, Andrew V. Schally, Jörg B. Engel, Ferenc G. Rick, Luca Szalontay, Florian Hohla, Awtar Krishan, Andrea Papadia, Timo Gaiser, Gero Brockhoff, Olaf Ortmann, Klaus Diedrich, Frank Köster*

*Corresponding author for this work
31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist Cetrorelix with growth inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences